Literature DB >> 27017863

Resection of Perihilar Cholangiocarcinoma.

Hermien Hartog1, Jan N M Ijzermans1, Thomas M van Gulik2, Bas Groot Koerkamp3.   

Abstract

Perihilar cholangiocarcinoma presents at the biliary and vascular junction of the hepatic hilum with a tendency to extend longitudinally into segmental bile ducts. Most patients show metastatic or unresectable disease at time of presentation or surgical exploration. In patients eligible for surgical resection, challenges are to achieve negative bile duct margins, adequate liver remnant function, and adequate portal and arterial inflow to the liver remnant. Surgical treatment is characterized by high rates of postoperative morbidity and mortality. This article reviews the various strategies and techniques, the role of staging laparoscopy, intraoperative frozen section, caudate lobectomy, and vascular reconstruction.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Caudate lobectomy; Hepatectomy; Perihilar cholangiocarcinoma; Staging laparoscopy; Vascular reconstruction

Mesh:

Year:  2016        PMID: 27017863     DOI: 10.1016/j.suc.2015.12.008

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  9 in total

1.  Survival after resection of perihilar cholangiocarcinoma in patients with lymph node metastases.

Authors:  Stefan Buettner; Jeroen L A van Vugt; Marcia P Gaspersz; Robert J S Coelen; Eva Roos; Tim A Labeur; Georgios A Margonis; Cecilia G Ethun; Shishir K Maithel; George Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Ryan C Fields; Bradley A Krasnick; Sharon M Weber; Ahmed Salem; Robert C G Martin; Charles R Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Jan N M IJzermans; Thomas M van Gulik; Timothy M Pawlik; Bas Groot Koerkamp
Journal:  HPB (Oxford)       Date:  2017-05-23       Impact factor: 3.647

2.  Does Caudate Resection Improve Outcomes of Patients Undergoing Curative Resection for Perihilar Cholangiocarcinoma? A Systematic Review and Meta-Analysis.

Authors:  Richard W D Gilbert; Tori Lenet; Sean P Cleary; Rory Smoot; Ching-Wei D Tzeng; Flavio G Rocha; Guillaume Martel; Kimberly A Bertens
Journal:  Ann Surg Oncol       Date:  2022-06-15       Impact factor: 4.339

Review 3.  Role of Intraductal RFA: A Novel Tool in the Palliative Care of Perihilar Cholangiocarcinoma.

Authors:  Tobias J Weismüller
Journal:  Visc Med       Date:  2021-01-07

4.  Outcome after resection for perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis: an international multicentre study.

Authors:  Hannes Jansson; Pim B Olthof; Annika Bergquist; Marjolein A P Ligthart; Silvio Nadalin; Roberto I Troisi; Bas Groot Koerkamp; Ruslan Alikhanov; Hauke Lang; Alfredo Guglielmi; Matteo Cescon; William R Jarnagin; Luca Aldrighetti; Thomas M van Gulik; Ernesto Sparrelid
Journal:  HPB (Oxford)       Date:  2021-04-28       Impact factor: 3.647

Review 5.  Intrahepatic cholangiocarcinoma: current perspectives.

Authors:  Stefan Buettner; Jeroen LA van Vugt; Jan Nm IJzermans; Bas Groot Koerkamp
Journal:  Onco Targets Ther       Date:  2017-02-22       Impact factor: 4.147

Review 6.  Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience.

Authors:  F Rassam; E Roos; K P van Lienden; J E van Hooft; H J Klümpen; G van Tienhoven; R J Bennink; M R Engelbrecht; A Schoorlemmer; U H W Beuers; J Verheij; M G Besselink; O R Busch; T M van Gulik
Journal:  Langenbecks Arch Surg       Date:  2018-01-19       Impact factor: 3.445

7.  Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma.

Authors:  Bas Groot Koerkamp; Stefan Buettner; Jaynee J A Vugts; Marcia P Gaspersz; Eva Roos; Lotte C Franken; Pim B Olthof; Robert J S Coelen; Jeroen L A van Vugt; Tim A Labeur; Lieke Brouwer; Marc G H Besselink; Jan N M IJzermans; Sarwa Darwish Murad; Thomas M van Gulik; Jeroen de Jonge; Wojciech G Polak; Olivier R C Busch; Joris L Erdmann
Journal:  Ann Surg Oncol       Date:  2020-09-08       Impact factor: 5.344

8.  Changing incidence and survival of intrahepatic cholangiocarcinoma based on Surveillance, Epidemiology, and End Results Database (2000-2017).

Authors:  Hassam Ali; Brandon Tedder; Syed Hamza Waqar; Rana Mohamed; Edward Lawson Cate; Eslam Ali
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2022-07-11

9.  Survival of Patients with Cholangiocarcinoma Receiving Surgical Treatment in an O. viverrini Endemic Area in Thailand: A Retrospective Cohort Study.

Authors:  Satsawat Chansitthichok; Parinya Chamnan; Poowanai Sarkhampee; Nithi Lertsawatvicha; Pim Voravisutthikul; Paiwan Wattanarath
Journal:  Asian Pac J Cancer Prev       Date:  2020-04-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.